Screening for Cognitive Impairment in Human Immunodeficiency Virus
Authors:
Open Access
- 15 September 2011
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 53 (8) , 836-842
Abstract
Recent publications estimate the prevalence of human immunodeficiency virus (HIV)–associated neurocognitive disorders (HAND) exceeds 50%, and this rate is likely higher among older patients. Cognitive impairment may impact medication adherence, and symptomatic impairment has been linked to all-cause mortality providing some impetus for early detection. There are currently insufficient data to inform solid recommendations on screening methods. Most HIV-specific tools have poor performance characteristics for all but the most severe form of impairment, which accounts for <5% of cases. Reliance on symptoms is likely to miss a substantial proportion of individuals with HAND due to poor insight, confounding mood disturbances, and lack of well-informed proxies. In the aging HIV-positive population, broader screening tools may be required to allow sensitivity for both HIV and neurodegenerative disorders. We describe the clinical presentation of HAND, review existing data related to screening tools, and provide preliminary and practical recommendations in the absence of more definitive studies.Keywords
This publication has 39 references indexed in Scilit:
- Concurrent Validity of a Computer-Based Cognitive Screening Tool for Use in Adults with HIV DiseaseAIDS Patient Care and STDs, 2011
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictorsJournal of NeuroVirology, 2010
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapyNeurology, 2010
- Neurologic disease burden in treated HIV/AIDS predicts survivalNeurology, 2010
- Medication and finance management among HIV-infected adults: The impact of age and cognitionJournal of Clinical and Experimental Neuropsychology, 2010
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performanceAIDS, 2009
- Cognitive Neuropsychology of HIV-Associated Neurocognitive DisordersNeuropsychology Review, 2009
- Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapyHIV Medicine, 2009
- Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapyJournal of NeuroVirology, 2008
- Predictive validity of demographically adjusted normative standards for the HIV Dementia ScaleJournal of Clinical and Experimental Neuropsychology, 2007